Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe plus low-dose atorvastatin versus atorvastatin alone for myocardial injury after PCI in unstable angina
ChiCTR-TRC-13003830Phase 4Completed
- Sponsor
- Cardiovascular Disease Center of the First Hospital of Jilin University
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ezetimibe and atorvastatin in unstable angina (3 arms), sponsored by Cardiovascular Disease Center of the First Hospital of Jilin University. Primary endpoint: Myocardial injury markers. Started Nov 2013; status: completed.
02
Drugs
ezetimibeatorvastatin
03
Conditions
unstable angina
Beyond the preview
Go deeper on ChiCTR-TRC-13003830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003830.